European Investment Bank banks on Israeli cell therapy
Regenerative medicine firm Pluristem gets €50 million venture debt loan, recently treated Covid-19 patients with its placenta-derived product.
MAY 12, 2020, 2:30 PM
Naama Barak is a writer at ISRAEL21c. A PhD student at the Hebrew University of Jerusalem, she loves all things history and politics. Food and fashion come a close second. Prior to joining ISRAEL21c, Naama worked for Israel's leading English-language dailies and cutting-edge startups.
No hay comentarios:
Publicar un comentario